Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent vaccine candidate, effective March 5, 2025. The company clarifies that the ...
Aurobindo Pharma Ltd share price was up by 0.59% from the previous closing price of ₹1,157.45. Who are peers of Aurobindo Pharma Ltd? The peers of Aurobindo Pharma Ltd are Sun Pharmaceutical ...
“We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. “Our team is committed to delivering tailored ...
Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker of Ozempic, Novo Nordisk.
18d
ET Now on MSNAurobindo's CuraTeq Biologics Aims Doubling Down on Biosimilar Launches - 2031 Plans REVEALED | ET NOW On The Go Hyderabad EditionAurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its subsidiary Theranym Biologics, has agreed on a contract to roll out a single ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
JPMorgan analyst Yang Huang initiated coverage of Ascentage Pharma (AAPG) with an Overweight rating and HK$52 price target The company’s Olverembatinib, having been approved for three CML ...
BERLIN, March 28, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...
ConfirmTkt, India's leading online train-utility and ticketing platform, has renewed its association with Royal Challengers ...
Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...
The Corporate Sustainability Due Diligence Directive (CSDDD) has been applied in both EU and non-EU pharma companies to promote ethical business practices. This policy was established to foster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results